Sign in
Active, not recruitingNo phase

Iliac Stent-Grafts in TASC C-D Lesions

Key facts

Who runs it
Samsun University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
52 people, planned
Started
1 Jan 2024
Ended
30 Aug 2025
Type of study
Observational
Record updated
20 July 2025

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients with TASC C-D iliac artery lesions
  • Procedures done within last 5 years in the same clinic
  • Aged between 18-85 years
  • Not eligible for open surgery or refused it

Who cannot take part

  • Age <18 or >85
  • TASC A-B lesions

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the midterm outcomes of patients with advanced aortoiliac artery narrowing (TASC C-D lesions) who were treated with covered iliac stent-grafts instead of open surgery. These patients were either too high-risk for surgery or refused it. Medical records from the past five years at a single cardiovascular surgery center in Turkey were reviewed retrospectively. The research focuses on the success rate of the procedure, complications, vessel patency, and the need for additional treatments. The results may help guide treatment decisions in similar high-risk patients who are not candidates for open vascular surgery.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Endovascular Treatment of TASC II C-D Iliac Artery Lesions Using Covered Stents: A Retrospective Cohort Study
Record updated
20 July 2025